Thursday, January 5, 2012

Map (MAPP) (MMM) (MNTA) (SGEN) (END) (CHH) Ratings, Price Targets

Map Pharmaceuticals (NASDAQ: MAPP), 3M Company (NYSE: MMM), Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), Seattle Genetics, Inc. (NASDAQ: SGEN), Endeavour International Co. (NYSE: END) and Choice Hotels (NYSE: CHH) ratings and price targets.

Map Pharmaceuticals (MAPP) is now covered by Canaccord Genuity. They have a “buy” rating and a price target of $24.00 on the firm.

3M Company (MMM) is now covered by Morgan Stanley (NYSE:MS). They have an “equal weight” rating and a price target of $90.00 on the firm.

Momenta Pharmaceuticals, Inc. (MNTA) is now covered by Sanford C. Bernstein. They placed an “outperform” rating on the firm.

Seattle Genetics, Inc. (SGEN) had its “sell” rating reiterated by Canaccord Genuity.

Endeavour International Co. (END) had its price target raised by Rodman & Renshaw from $12.50 to $15.00. They have an “outperform” rating on the firm.

Choice Hotels (CHH) was downgraded by Robert W. Baird from a “neutral” rating to an “underperform” rating. They have a price target of $34.00 on the firm, up from $33.00.

No comments:

Post a Comment